HELB2_ASPFU
ID HELB2_ASPFU Reviewed; 507 AA.
AC Q4WR18;
DT 25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2005, sequence version 1.
DT 03-AUG-2022, entry version 101.
DE RecName: Full=Cytochrome P450 monooxygenase helB2 {ECO:0000303|PubMed:25311525};
DE EC=1.-.-.- {ECO:0000269|PubMed:19415934, ECO:0000269|PubMed:29158519};
DE AltName: Full=Helvolic acid biosynthesis cluster protein B2 {ECO:0000303|PubMed:25311525};
DE Flags: Precursor;
GN Name=helB2 {ECO:0000303|PubMed:29158519};
GN Synonyms=cyp5081B1 {ECO:0000303|PubMed:19415934}; ORFNames=AFUA_4G14790;
OS Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC
OS A1100) (Aspergillus fumigatus).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC Aspergillus subgen. Fumigati.
OX NCBI_TaxID=330879;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX PubMed=16372009; DOI=10.1038/nature04332;
RA Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J.,
RA Berriman M., Abe K., Archer D.B., Bermejo C., Bennett J.W., Bowyer P.,
RA Chen D., Collins M., Coulsen R., Davies R., Dyer P.S., Farman M.L.,
RA Fedorova N., Fedorova N.D., Feldblyum T.V., Fischer R., Fosker N.,
RA Fraser A., Garcia J.L., Garcia M.J., Goble A., Goldman G.H., Gomi K.,
RA Griffith-Jones S., Gwilliam R., Haas B.J., Haas H., Harris D.E.,
RA Horiuchi H., Huang J., Humphray S., Jimenez J., Keller N., Khouri H.,
RA Kitamoto K., Kobayashi T., Konzack S., Kulkarni R., Kumagai T., Lafton A.,
RA Latge J.-P., Li W., Lord A., Lu C., Majoros W.H., May G.S., Miller B.L.,
RA Mohamoud Y., Molina M., Monod M., Mouyna I., Mulligan S., Murphy L.D.,
RA O'Neil S., Paulsen I., Penalva M.A., Pertea M., Price C., Pritchard B.L.,
RA Quail M.A., Rabbinowitsch E., Rawlins N., Rajandream M.A., Reichard U.,
RA Renauld H., Robson G.D., Rodriguez de Cordoba S., Rodriguez-Pena J.M.,
RA Ronning C.M., Rutter S., Salzberg S.L., Sanchez M., Sanchez-Ferrero J.C.,
RA Saunders D., Seeger K., Squares R., Squares S., Takeuchi M., Tekaia F.,
RA Turner G., Vazquez de Aldana C.R., Weidman J., White O., Woodward J.R.,
RA Yu J.-H., Fraser C.M., Galagan J.E., Asai K., Machida M., Hall N.,
RA Barrell B.G., Denning D.W.;
RT "Genomic sequence of the pathogenic and allergenic filamentous fungus
RT Aspergillus fumigatus.";
RL Nature 438:1151-1156(2005).
RN [2]
RP INDUCTION.
RX PubMed=17432932; DOI=10.1371/journal.ppat.0030050;
RA Perrin R.M., Fedorova N.D., Bok J.W., Cramer R.A., Wortman J.R., Kim H.S.,
RA Nierman W.C., Keller N.P.;
RT "Transcriptional regulation of chemical diversity in Aspergillus fumigatus
RT by LaeA.";
RL PLoS Pathog. 3:E50-E50(2007).
RN [3]
RP FUNCTION, AND PATHWAY.
RX PubMed=19415934; DOI=10.1021/ja8095976;
RA Mitsuguchi H., Seshime Y., Fujii I., Shibuya M., Ebizuka Y., Kushiro T.;
RT "Biosynthesis of steroidal antibiotic fusidanes: functional analysis of
RT oxidosqualene cyclase and subsequent tailoring enzymes from Aspergillus
RT fumigatus.";
RL J. Am. Chem. Soc. 131:6402-6411(2009).
RN [4]
RP FUNCTION.
RX PubMed=19216560; DOI=10.1021/ol802696a;
RA Lodeiro S., Xiong Q., Wilson W.K., Ivanova Y., Smith M.L., May G.S.,
RA Matsuda S.P.;
RT "Protostadienol biosynthesis and metabolism in the pathogenic fungus
RT Aspergillus fumigatus.";
RL Org. Lett. 11:1241-1244(2009).
RN [5]
RP INDUCTION.
RX PubMed=25311525; DOI=10.1186/1471-2164-15-894;
RA O'Keeffe G., Hammel S., Owens R.A., Keane T.M., Fitzpatrick D.A.,
RA Jones G.W., Doyle S.;
RT "RNA-seq reveals the pan-transcriptomic impact of attenuating the gliotoxin
RT self-protection mechanism in Aspergillus fumigatus.";
RL BMC Genomics 15:894-894(2014).
RN [6]
RP FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX PubMed=29158519; DOI=10.1038/s41467-017-01813-9;
RA Lv J.M., Hu D., Gao H., Kushiro T., Awakawa T., Chen G.D., Wang C.X.,
RA Abe I., Yao X.S.;
RT "Biosynthesis of helvolic acid and identification of an unusual C-4-
RT demethylation process distinct from sterol biosynthesis.";
RL Nat. Commun. 8:1644-1644(2017).
CC -!- FUNCTION: Cytochrome P450 monooxygenase; part of the gene cluster that
CC mediates the biosynthesis of helvolic acid, an antibacterial
CC nortriterpenoid (PubMed:19415934, PubMed:19216560, PubMed:29158519).
CC Protostadienol synthase helA cyclizes (3S)-oxidosqualene to (17Z)-
CC protosta-17(20),24-dien-3-beta-ol (protostadienol)(PubMed:19415934,
CC PubMed:19216560, PubMed:29158519). The synthesis of protostadienol is
CC followed by several steps of monooxygenation, dehydrogenation, and acyl
CC transfer to yield the final helvolic acid (PubMed:19216560). Following
CC the cyclization to the tetracyclic protostadienol by helA, cytochrome
CC P450 monooxygenases helB1-mediated and helB2-mediated oxidation at C-4
CC and C-16, acyltransferase helD2-dependent acetylation of 16-OH,
CC oxidation of C-21 by cytochrome P450 monooxygenase helB4, and short
CC chain dehydrogenase helC-dependent oxidative decarboxylation yield the
CC fusidane skeleton (PubMed:29158519). This intermediate is further
CC modified in three additional steps mediated by the cytochrome P450
CC monooxygenase helB3, the acyltransferase helD1, and the 3-ketosteroid
CC 1-dehydrogenase helE to give helvolic acid (PubMed:19415934,
CC PubMed:19216560, PubMed:29158519). Compared with the late stages in the
CC biosynthesis of helvolic acid, enzymes involved in the early stage
CC modifications act in a relatively strict order (PubMed:29158519). The
CC hydroxylation of C-16 by helB1 and subsequent acetylation by helD2
CC should occur before the helB3-mediated oxidation of C-21
CC (PubMed:29158519). C-4 demethylation in fusidane-type antibiotics
CC proceeds in an unusual manner though it is also achieved by oxidative
CC decarboxylation (PubMed:19415934, PubMed:29158519). The methyl group at
CC C-4 beta position is oxidized by helB1 and subsequently removed by the
CC short chain dehydrogenase helC (PubMed:19415934, PubMed:29158519).
CC {ECO:0000269|PubMed:19216560, ECO:0000269|PubMed:19415934,
CC ECO:0000269|PubMed:29158519}.
CC -!- COFACTOR:
CC Name=heme; Xref=ChEBI:CHEBI:30413;
CC Evidence={ECO:0000250|UniProtKB:P04798};
CC -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:29158519,
CC ECO:0000305|PubMed:19415934}.
CC -!- INDUCTION: Expression is under the control of the secondary metabolism
CC regulator laeA (PubMed:17432932). Expression is completely abrogated
CC when gliT is deleted in cells exposed to exogenous gliotoxin
CC (PubMed:25311525). {ECO:0000269|PubMed:17432932,
CC ECO:0000269|PubMed:25311525}.
CC -!- SIMILARITY: Belongs to the cytochrome P450 family.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AAHF01000005; EAL89316.1; -; Genomic_DNA.
DR RefSeq; XP_751354.1; XM_746261.1.
DR AlphaFoldDB; Q4WR18; -.
DR SMR; Q4WR18; -.
DR STRING; 746128.CADAFUBP00007022; -.
DR EnsemblFungi; EAL89316; EAL89316; AFUA_4G14790.
DR GeneID; 3509335; -.
DR KEGG; afm:AFUA_4G14790; -.
DR VEuPathDB; FungiDB:Afu4g14790; -.
DR eggNOG; KOG0156; Eukaryota.
DR HOGENOM; CLU_001570_14_2_1; -.
DR InParanoid; Q4WR18; -.
DR OMA; VEWIMAT; -.
DR OrthoDB; 702827at2759; -.
DR Proteomes; UP000002530; Chromosome 4.
DR GO; GO:0020037; F:heme binding; IEA:InterPro.
DR GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR GO; GO:1900812; P:helvolic acid biosynthetic process; IDA:GO_Central.
DR GO; GO:0019748; P:secondary metabolic process; IGC:AspGD.
DR Gene3D; 1.10.630.10; -; 1.
DR InterPro; IPR001128; Cyt_P450.
DR InterPro; IPR017972; Cyt_P450_CS.
DR InterPro; IPR002401; Cyt_P450_E_grp-I.
DR InterPro; IPR036396; Cyt_P450_sf.
DR Pfam; PF00067; p450; 1.
DR PRINTS; PR00463; EP450I.
DR PRINTS; PR00385; P450.
DR SUPFAM; SSF48264; SSF48264; 1.
DR PROSITE; PS00086; CYTOCHROME_P450; 1.
PE 1: Evidence at protein level;
KW Heme; Iron; Metal-binding; Monooxygenase; Oxidoreductase;
KW Reference proteome; Signal.
FT SIGNAL 1..22
FT /evidence="ECO:0000255"
FT CHAIN 23..507
FT /note="Cytochrome P450 monooxygenase helB2"
FT /evidence="ECO:0000255"
FT /id="PRO_0000441948"
FT BINDING 436
FT /ligand="heme"
FT /ligand_id="ChEBI:CHEBI:30413"
FT /ligand_part="Fe"
FT /ligand_part_id="ChEBI:CHEBI:18248"
FT /note="axial binding residue"
FT /evidence="ECO:0000250|UniProtKB:P04798"
SQ SEQUENCE 507 AA; 57810 MW; 16F1DE6E90612F32 CRC64;
MALPIILCLA VILWTSWRLL DALFLSPLHR VPGPVLARLT PLRAIYARLP SRVIPAALAD
FHSYGDIYLS KPRTITISHP RDVRAILASS EFQKIDVYHG LNDPVMANIV TFSDPKLASR
RRRQIGPYFN PSYLAKMEEL ILRCGCRAVA DKWGRLIAQQ GHGPQKSVKV NYRHDLQLAT
FDIMSALAFG RWLDSLKEEG ESVAIVEWIM ATAVYIGVRI NFRLLMVFPF SRLVRRWTRA
YAEFVQFSKH AVASRKELLA QGCQKPVDLL QAFIDAEDPD SKVKMTTVEV QAESVGMQLA
GSETTAASLT WAVHLFTLYP EYYRIAVDEV RGQFGPNHLI TYADCSRLVF LEAFVYEMLR
YTPITSSFMP RVSFTKGTTL QGHYIPPGTE IAFNLIAMNN REDVWEEPER FLPDRFLKDP
DLKRSVFAFS YGTRSCIGRH LAWMEMMTIL ANLLKDYDWS LPEDSLYGPH HVDEKGIPIR
MPSKCHIVFA PTHPDRDCQL VISRPKT